212. Tricuspid atresia Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 5 Drugs : 5 - (DrugBank : 6) / Drug target genes : 8 - Drug target pathways : 13

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Bosentan
   Rigshospitalet, Denmark
      2011   Phase 2   NCT01292551   Denmark;Sweden
Dexmedetomidine
   Athena Zuppa
      2004   Phase 1   NCT00573066   -
Liothyronine I 131
   FDA Office of Orphan Products Development
      1994   Phase 1   NCT00004828   -
Sildenafil
   Children's Hospital of Philadelphia
      2007   Phase 2   NCT00507819   United States
Vitamin C
   University of Michigan
      2009   -   NCT00974025   United States